| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus (CN3 + coagulase-negative + methicillin-susceptible) |
- |
- |
0.5 － ? |
Oritavancin (LY333328)  |
72 |
| Staphylococcus (CN3 + coagulase-negative + methicillin-susceptible) |
- |
- |
2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
72 |
| Staphylococcus (CN3 + coagulase-negative + methicillin-susceptible) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
72 |
| Staphylococcus (CN3 + coagulase-negative + methicillin-susceptible) |
- |
- |
4 － ? |
Teicoplanin (Targocid) |
72 |
| Staphylococcus (CN5 + coagulase-negative + methicillin-resistant) |
- |
- |
0.12 － ? |
Ranbezolid (RBX 7644) |
72 |
| Staphylococcus (CN5 + coagulase-negative + methicillin-resistant) |
- |
- |
0.25 － ? |
Daptomycin (Cubicin) |
72 |
| Staphylococcus (CN5 + coagulase-negative + methicillin-resistant) |
- |
- |
0.25 － ? |
Quinupristin/Dalfopristin (Synercid) |
72 |
| Staphylococcus (CN5 + coagulase-negative + methicillin-resistant) |
- |
- |
1 － ? |
Oritavancin (LY333328) |
72 |
| Staphylococcus (CN5 + coagulase-negative + methicillin-resistant) |
- |
- |
2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
72 |
| Staphylococcus (CN5 + coagulase-negative + methicillin-resistant) |
- |
- |
4 － ? |
Teicoplanin (Targocid) |
72 |
| Staphylococcus (CN5 + coagulase-negative + methicillin-resistant) |
- |
- |
4 － ? |
Vancomycin (Vancocyn, Lyphocin) |
72 |
| Staphylococcus (coagulase-negative + fluoroquinolone-resistant) |
- |
2 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
66 |
| Staphylococcus (coagulase-negative + fluoroquinolone-resistant) |
- |
3 |
? － ? |
Gatifloxacin (Tequin) |
66 |
| Staphylococcus (coagulase-negative + fluoroquinolone-resistant) |
- |
3 |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
66 |
| Staphylococcus (coagulase-negative + fluoroquinolone-resistant) |
- |
64 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
66 |
| Staphylococcus (coagulase-negative + fluoroquinolone-resistant) |
- |
64 |
? － ? |
Ofloxacin (Floxin) |
66 |
| Staphylococcus (coagulase-negative + fluoroquinolone-susceptible) |
0.125 |
- |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
66 |
| Staphylococcus (coagulase-negative + fluoroquinolone-susceptible) |
- |
0.19 |
? － ? |
Gatifloxacin (Tequin) |
66 |
| Staphylococcus (coagulase-negative + fluoroquinolone-susceptible) |
- |
0.19 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
66 |
| Staphylococcus (coagulase-negative + fluoroquinolone-susceptible) |
- |
0.75 |
? － ? |
Ofloxacin (Floxin) |
66 |
| Staphylococcus (coagulase-negative + fluoroquinolone-susceptible) |
- |
64 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
66 |
| Staphylococcus (coagulase-negative + methicillin-resistant + ampicillin-resistant + cefazolin-resistant) |
2 |
16 |
1 － 32 |
Cefquinome |
1486 |
| Staphylococcus (coagulase-negative + methicillin-resistant + ampicillin-resistant + cefazolin-resistant) |
4 |
32 |
1 － 64 |
Cefpirome |
1486 |
| Staphylococcus (coagulase-negative + methicillin-resistant + ampicillin-resistant + cefazolin-resistant) |
16 |
64 |
1 － >64 |
Cefepime (Maxipime) |
1486 |
| Staphylococcus (coagulase-negative + methicillin-resistant + ampicillin-resistant + cefazolin-resistant) |
32 |
>64 |
8 － >64 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1486 |
| Staphylococcus (coagulase-negative + methicillin-resistant) |
- |
0.25 |
? － ? |
Dalbavancin |
1112 |
| Staphylococcus (coagulase-negative + methicillin-resistant) |
- |
0.28 |
≤0.008 － 1 |
Dalbavancin |
1112 |
| Staphylococcus (coagulase-negative + methicillin-resistant) |
- |
0.5 |
? － ? |
Daptomycin (Cubicin) |
1112 |